Benchmark: Maintaining the Cardio Diagnostics Hldgs (CDIO.US) rating, adjusted from Speculative Buy to Specified Buy, and adjusted the target price from $4.00 to $1.35.
Zhitong FinanceApr 19 19:50
Cardio Diagnostics Hldgs Analyst Ratings
BenzingaApr 19 19:44
Benchmark Co. Sticks to Their Buy Rating for Cardio Diagnostics Holdings (CDIO)
TipRanksJun 16, 2023 00:26
Benchmark Reiterates Speculative Buy on Cardio Diagnostics Hldgs, Maintains $8 Price Target
BenzingaJun 15, 2023 20:18
Northland Capital Markets Initiates Coverage On Cardio Diagnostics Hldgs With Outperform Rating, Announces Price Target of $8
BenzingaMay 22, 2023 20:17
Analysts Offer Insights on Healthcare Companies: NanoViricides (NNVC) and Cardio Diagnostics Holdings (CDIO)
TipRanksApr 19, 2023 00:36
Benchmark Reiterates Speculative Buy on Cardio Diagnostics Hldgs, Maintains $8 Price Target
BenzingaApr 18, 2023 19:35
No Data
No Data